4.7 Article

Comparison of phantom and registration scaling corrections using the ADNI cohort

期刊

NEUROIMAGE
卷 47, 期 4, 页码 1506-1513

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2009.05.045

关键词

Scanner drift; Registration; Brain atrophy; Boundary shift integral; Alzheimer's disease

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) [U01 AG024904]
  2. National Institute on Aging
  3. National institute of Biomedical Imaging and Bioengineering (NIBIB)
  4. Pfizer Inc.
  5. Wyeth Research
  6. Bristol-Myers Squibb
  7. Eli Lilly and Company
  8. GIaxoSmithKline
  9. Merck Co. Inc.
  10. AstraZeneca AB
  11. Novartis Pharmaceuticals Corporation
  12. Alzheimer's Association
  13. Eisai Global Clinical Development
  14. Elan Corporation plc
  15. Forest Laboratories
  16. Institute for the Study of Aging
  17. Department of Health's NIHR Biomedical Research Centres
  18. The Dementia Research Centre is an Alzheimer's Research Trust Co-ordinating centre
  19. TSB [M1638A]
  20. Alzheimer's Research Trust (UK) Research Fellowship
  21. MRC (UK)
  22. MRC [G0601846] Funding Source: UKRI
  23. Alzheimers Research UK [ART-RF2007-1] Funding Source: researchfish
  24. Medical Research Council [G0601846] Funding Source: researchfish
  25. National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish

向作者/读者索取更多资源

Rates of brain atrophy derived from serial magnetic resonance (MR) studies may be used to assess therapies for Alzheimer's disease (AD). These measures may be confounded by changes in scanner voxel sizes. For this reason, the Alzheimer's Disease Neuroimaging Initiative (ADNI) included the imaging of a geometric phantom with every scan. This study compares voxel scaling correction using a phantom with correction using a 9 degrees of freedom (9DOF) registration algorithm. We took 129 pairs of baseline and 1-year repeat scans, and calculated the volume scaling correction, previously measured using the phantom. We used the registration algorithm to quantify any residual scaling errors, and found the algorithm to be unbiased, with no significant (p=0.97) difference between control (n=79) and AD subjects (n=50), but with a mean (SD) absolute volume change of 0.20 (0.20) % due to linear scalings. 9DOF registration was shown to be comparable to geometric phantom correction in terms of the effect on atrophy measurement and unbiased with respect to disease status. These results suggest that the additional expense and logistic effort of scanning a phantom with every patient scan can be avoided by registration-based scaling correction. Furthermore, based upon the atrophy rates in the AD subjects in this study, sample size requirements would be approximately 10-12% lower with (either) correction for voxel scaling than if no correction was used. (C) 2009 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据